DeutschTechnology platforms and service laboratories
State-of-the-art technologies for cell analysis
Latest technologies for molecular disease definition
With its state-of-the-art technology platforms, the DRFZ is revolutionising the way in which immune cells and their complex interactions are studied in the natural tissue environment. These platforms make it possible not only to observe and identify immune cells in their natural environment, but also to isolate them in a targeted manner. Once isolated, these cells are further analysed in in-depth molecular and functional studies.
Our platforms for cytometry, microscopy and genetics offer far more than just a service for the research groups; they are also innovation centres that are constantly developing new technologies to identify, isolate or eliminate cells more efficiently. Operated in close co-operation with the Charité and the Max Planck Institute for Infection Biology, these laboratories ensure that our research groups receive not only technological but also logistical support. This support enables them to conduct their studies to the highest standards of standardisation and quality control, driving the development of precise, innovative treatments.
The DRFZ is expanding its technology platforms with a state-of-the-art robotics platform specialising in the automated processing of patient samples and blood products. This platform integrates state-of-the-art robotic technologies to handle samples efficiently and with the highest precision, significantly increasing the speed and accuracy of analysis.
Automated processing minimises the risk of human error and enables consistent quality of sample processing. This is particularly critical for the standardised execution of complex experimental protocols. In addition, the robotics platform supports the DRFZ’s research groups by optimising workflows and speeding up turnaround times, which accelerates the discovery and development of new therapeutic approaches.
Together with the existing platforms for cytometry, microscopy and genetics, the robotics platform forms an integrated system that enables the research groups to develop innovative treatments faster and more efficiently than ever before.
